The second mutation of SYCE1 gene associated with autosomal recessive nonobstructive azoospermia.


Journal

Journal of assisted reproduction and genetics
ISSN: 1573-7330
Titre abrégé: J Assist Reprod Genet
Pays: Netherlands
ID NLM: 9206495

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 09 09 2019
accepted: 12 12 2019
pubmed: 10 1 2020
medline: 15 12 2020
entrez: 10 1 2020
Statut: ppublish

Résumé

It is estimated that 40-50% of infertility among human couples is due to male infertility. Azoospermia is estimated to occur in 1% of all men and to be the cause of 10-20% of male infertility. Genetic defects, including single gene effects, maybe cause of azoospermia in 20-30% of affected males. Here, we aim to identify the genetic cause of azoospermia in a man who is also affected by hereditary spastic paraplegia. The proband was subjected to whole-exome sequencing, followed by a comprehensive in silico analysis to identify the azoospermia causative gene. A novel splice site mutation c.375-2A > G in SYCE1 that is thought to be the cause of azoospermia was identified. This variant co-segregated with azoospermia status in the family that has three additional affected males. SYCE1 gene encodes synaptonemal complex (SC) central element 1 protein which contributes to the formation of the synaptonemal complex during meiosis. Syce1 null male and female mice have been shown to be infertile. There have only been two reports on the effects of SYCE1 mutations in humans; it was shown as the cause of primary ovarian failure (POI) in one and as the cause of nonobstructive azoospermia (NOA) in another. We suggest that the mutation 375-2A > G, which affects the acceptor splice site within intron 6 of SYCE1, is the likely cause of azoospermia and subsequent infertility in the family studied. The finding constitutes the third report of SYCE1mutations that affect infertility in humans and further supports its contribution to this condition.

Identifiants

pubmed: 31916078
doi: 10.1007/s10815-019-01660-1
pii: 10.1007/s10815-019-01660-1
pmc: PMC7056785
doi:

Substances chimiques

Codon, Nonsense 0
DNA-Binding Proteins 0
RNA Splice Sites 0
SYCP1 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

451-458

Subventions

Organisme : National Institute for Medical Research Development
ID : 963846
Organisme : University of Social Welfare and Rehabilitation Sciences (IR)
ID : --

Références

Zegers-Hochschild F, Adamson G, de Mouzon J, Ishihara O, Mansour R, Nygren K, et al. Technology ICfMAR, organization WH. The international committee for monitoring assisted reproductive technology (ICMART) and the world health organization (WHO) revised glossary on ART terminology, 2009. Fertil Steril. 2009;92(5):1520–4.
doi: 10.1016/j.fertnstert.2009.09.009
Rapino C, Battista N, Bari M, Maccarrone M. Endocannabinoids as biomarkers of human reproduction. Hum Reprod Update. 2014;20(4):501–16.
doi: 10.1093/humupd/dmu004
Di Spiezio SA, Di Carlo C, Minozzi S, Spinelli M, Pistotti V, Alviggi C, et al. Efficacy of hysteroscopy in improving reproductive outcomes of infertile couples: a systematic review and meta-analysis. Hum Reprod Update. 2016;22(4):479–96.
doi: 10.1093/humupd/dmw008
Miyamoto T, Minase G, Shin T, Ueda H, Okada H, Sengoku K. Human male infertility and its genetic causes. Reprod Med Biol. 2017;16(2):81–8.
doi: 10.1002/rmb2.12017
Jarow JP, Espeland MA, Lipshultz LI. Evaluation of the azoospermic patient. J Urol. 1989;142(1):62–5.
doi: 10.1016/S0022-5347(17)38662-7
Gudeloglu A, Parekattil SJ. Update in the evaluation of the azoospermic male. Clinics. 2013;68:27–34.
doi: 10.6061/clinics/2013(Sup01)04
Rowe PJ, Comhaire FH, Hargreave TB, Mahmoud AM. WHO manual for the standardized investigation, Diagnosis and Management of the Infertile Male. 1rd ed. Cambridge: Cambridge University Press; 2000.
Maor-Sagie E, Cinnamon Y, Yaacov B, Shaag A, Goldsmidt H, Zenvirt S, et al. Deleterious mutation in SYCE1 is associated with non-obstructive azoospermia. J Assist Reprod Genet. 2015;32(6):887–91.
doi: 10.1007/s10815-015-0445-y
Krausz C, Riera-Escamilla A. Genetics of male infertility. Nat Rev Urol. 2018;15(6):369–384.
doi: 10.1038/s41585-018-0003-3
Oud MS, Volozonoka L, Smits RM, Vissers LE, Ramos L, Veltman JA. A systematic review and standardized clinical validity assessment of male infertility genes. Hum Reprod. 2019;34(5):932–41.
doi: 10.1093/humrep/dez022
Hamada AJ, Esteves SC, Agarwal A. A comprehensive review of genetics and genetic testing in azoospermia. Clinics. 2013;68:39–60.
doi: 10.6061/clinics/2013(Sup01)06
Lee JY, Dada R, Sabanegh E, Carpi A, Agarwal A. Role of genetics in azoospermia. Urology. 2011;77(3):598–601.
doi: 10.1016/j.urology.2010.10.001
Vog P, Edelmann A, Kirsch S, Henegariu O, Hirschmann P, Kiesewetter F, et al. Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet. 1996;5(7):933–43.
doi: 10.1093/hmg/5.7.933
Harton GL, Tempest HG. Chromosomal disorders and male infertility. Asian J Androl. 2012;14(1):32–9.
doi: 10.1038/aja.2011.66
Eggers S, DeBoer KD, van den Bergen J, Gordon L, White SJ, Jamsai D, et al. Copy number variation associated with meiotic arrest in idiopathic male infertility. Fertil Steril. 2015;103(1):214–9.
doi: 10.1016/j.fertnstert.2014.09.030
Schilit SL, Menon S, Friedrich C, Kammin T, Wilch E, Hanscom C, et al. SYCP2 translocation-mediated dysregulation and frameshift variants cause human male infertility. bioRxiv. 2019;pii: S0002–9297(19)30434–3.
Miyamoto T, Hasuike S, Yogev L, Maduro MR, Ishikawa M, Westphal H, et al. Azoospermia in patients heterozygous for a mutation in SYCP3. Lancet. 2003;362(9397):1714–9.
doi: 10.1016/S0140-6736(03)14845-3
He W-B, Tu C-F, Liu Q, Meng L-L, Yuan S-M, Luo A-X, et al. DMC1 mutation that causes human non-obstructive azoospermia and premature ovarian insufficiency identified by whole-exome sequencing. J Med Genet. 2018;55(3):198–204.
pubmed: 29331980
Zhang YX, Li HY, He WB, Tu C, Du J, Li W, et al. XRCC2 mutation causes premature ovarian insufficiency as well as non-obstructive azoospermia in humans. Clin Genet. 2019;95(3):442–3.
doi: 10.1111/cge.13475
de Vries LBD, Smirin-Yosef P, Lagovsky I, Tzur S, Basel-Vanagaite L. Exome sequencing reveals SYCE1 mutation associated with autosomal recessive primary ovarian insufficiency. J Clin Endocrinol Metab. 2014;99(10):E2129–E32.
doi: 10.1210/jc.2014-1268
Reese MG, Eeckman FH, Kulp D, Haussler D. Improved splice site detection in genie. J Comput Biol. 1997;4(3):311–23.
doi: 10.1089/cmb.1997.4.311
Desmet F-O, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res, 2009. 37(9):e67.
doi: 10.1093/nar/gkp215
Geisinger A, Benavente R. Mutations in genes coding for synaptonemal complex proteins and their impact on human fertility. Cytogenet Genome Res. 2016;150(2):77–85.
doi: 10.1159/000453344
Dunne OM, Davies OR. Molecular structure of human synaptonemal complex protein SYCE1. Chromosoma. 2019:128(3):223–236.
doi: 10.1007/s00412-018-00688-z
Liu J-G, Yuan L, Brundell E, Björkroth B, Daneholt B, Höög C. Localization of the N-terminus of SCP1 to the central element of the synaptonemal complex and evidence for direct interactions between the N-termini of SCP1 molecules organized head-to-head. Exp Cell Res. 1996;226(1):11–9.
doi: 10.1006/excr.1996.0197
Bolcun-Filas E, Costa Y, Speed R, Taggart M, Benavente R, De Rooij DG, et al. SYCE2 is required for synaptonemal complex assembly, double strand break repair, and homologous recombination. J Cell Biol. 2007;176(6):741–7.
doi: 10.1083/jcb.200610027
Hamer G, Gell K, Kouznetsova A, Novak I, Benavente R, Höög C. Characterization of a novel meiosis-specific protein within the central element of the synaptonemal complex. J Cell Sci. 2006;119(19):4025–32.
doi: 10.1242/jcs.03182
Yang F, De La Fuente R, Leu NA, Baumann C, McLaughlin KJ, Wang PJ. Mouse SYCP2 is required for synaptonemal complex assembly and chromosomal synapsis during male meiosis. J Cell Biol. 2006;173(4):497–507.
doi: 10.1083/jcb.200603063
Yuan L, Liu J-G, Zhao J, Brundell E, Daneholt B, Höög C. The murine SCP3 gene is required for synaptonemal complex assembly, chromosome synapsis, and male fertility. Mol Cell. 2000;5(1):73–83.
doi: 10.1016/S1097-2765(00)80404-9
Costa Y, Speed R, Öllinger R, Alsheimer M, Semple CA, Gautier P, et al. Two novel proteins recruited by synaptonemal complex protein 1 (SYCP1) are at the centre of meiosis. J Cell Sci. 2005;118(12):2755–62.
doi: 10.1242/jcs.02402
Davies OR, Maman JD, Pellegrini L. Structural analysis of the human SYCE2–TEX12 complex provides molecular insights into synaptonemal complex assembly. Open Biol. 2012;2(7):120099.
doi: 10.1098/rsob.120099
Schramm S, Fraune J, Naumann R, Hernandez-Hernandez A, Höög C, Cooke HJ, et al. A novel mouse synaptonemal complex protein is essential for loading of central element proteins, recombination, and fertility. PLoS Genet. 2011;7(5):e1002088.
doi: 10.1371/journal.pgen.1002088
Bolcun-Filas E, Speed R, Taggart M, Grey C, de Massy B, Benavente R, et al. Mutation of the mouse Syce1 gene disrupts synapsis and suggests a link between synaptonemal complex structural components and DNA repair. PLoS Genet. 2009;5(2):e1000393.
doi: 10.1371/journal.pgen.1000393
de Vries FA, de Boer E, van den Bosch M, Baarends WM, Ooms M, Yuan L, et al. Mouse Sycp1 functions in synaptonemal complex assembly, meiotic recombination, and XY body formation. Genes Dev. 2005;19(11):1376–89.
doi: 10.1101/gad.329705
Hamer G, Wang H, Bolcun-Filas E, Cooke HJ, Benavente R, Höög C. Progression of meiotic recombination requires structural maturation of the central element of the synaptonemal complex. J Cell Sci. 2008;121(15):2445–51.
doi: 10.1242/jcs.033233
Nishiyama S, Kishi T, Kato T, Suzuki M, Bolor H, Nishizawa H, et al. A rare synaptonemal complex protein 3 gene variant in unexplained female infertility. Mol Hum Reprod. 2010;17(4):266–71.
doi: 10.1093/molehr/gaq098
Lu J, Gu Y, Feng J, Zhou W, Yang X, Shen Y. Structural insight into the central element assembly of the synaptonemal complex. Sci Rep. 2014;4:7059.
doi: 10.1038/srep07059

Auteurs

Mahdieh Pashaei (M)

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Mohammad Masoud Rahimi Bidgoli (MM)

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Davood Zare-Abdollahi (D)

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Hossein Najmabadi (H)

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Ramona Haji-Seyed-Javadi (R)

Department of Radiation Oncology, Winship Cancer Institute of Emory University, Emory University School of Medicine, Atlanta, GA, 30322, USA.

Farzad Fatehi (F)

Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. f-fatehi@tums.ac.ir.

Afagh Alavi (A)

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. afaghalavi@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH